Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Barr

Showing results (831-840 of 1,036) with videos related to

Pageof 104
Sort By:
Medicine and Science in Sports and Exercise|September 2, 2020
Mortality Effects of Hypothetical Interventions on Physical Activity and TV ViewingY I Yang, Allison M Hodge, Pierre-Antoine Dugué, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 2004
Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim testsTamas Bartfai, Xiaoying Lu, Hedieh Badie-Mahdavi, et al.
Journal of Neurointerventional Surgery|July 30, 2015
MACRA: background, opportunities and challenges for the neurointerventional specialistJoshua A Hirsch, Thabele M Leslie-Mazwi, Aman B Patel, et al.
Plos One|December 4, 2009
The E3 ubiquitin-ligase Bmi1/Ring1A controls the proteasomal degradation of Top2alpha cleavage complex - a potentially new drug targetIris Alchanati, Carmit Teicher, Galit Cohen, et al.
British Journal of Haematology|November 28, 2018
Venetoclax for chronic lymphocytic leukaemia patients who progress after more than one B-cell receptor pathway inhibitorWilliam G Wierda, John C Byrd, Matthew S Davids, et al.
The Medical Journal of Australia|August 27, 2009
Health and mortality consequences of abdominal obesity: evidence from the AusDiab studyAdrian J Cameron, David W Dunstan, Neville Owen, et al.
Blood|March 23, 2017
Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapyAjay K Gopal, Brad S Kahl, Christopher R Flowers, et al.
Genome Research|August 26, 2016
A generic, cost-effective, and scalable cell lineage analysis platformTamir Biezuner, Adam Spiro, Ofir Raz, et al.
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|August 7, 2020
Treatment algorithm for the use of psychopharmacological agents in individuals prenatally exposed to alcohol and/or with diagnosis of fetal alcohol spectrum disorder (FASD)Mansfield Mela, Ana Hanlon-Dearman, A G Ahmed, et al.
American Journal of Hematology|January 2, 2025
Treatment of Relapsed/Refractory CLL Patients With PI3Kδ Inhibitor and Anti-CD20 Antibody Rapidly Decreases Tumor Burden but Could Induce ResistanceJennifer E Bruno, Christine A Herne, Andrea M Baran, et al.
Pageof 104

Showing results (831-840 of 1,036) with videos related to

Sort By:
Pageof 104
Medicine and Science in Sports and Exercise|September 2, 2020
Mortality Effects of Hypothetical Interventions on Physical Activity and TV ViewingY I Yang, Allison M Hodge, Pierre-Antoine Dugué, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 2004
Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim testsTamas Bartfai, Xiaoying Lu, Hedieh Badie-Mahdavi, et al.
Journal of Neurointerventional Surgery|July 30, 2015
MACRA: background, opportunities and challenges for the neurointerventional specialistJoshua A Hirsch, Thabele M Leslie-Mazwi, Aman B Patel, et al.
Plos One|December 4, 2009
The E3 ubiquitin-ligase Bmi1/Ring1A controls the proteasomal degradation of Top2alpha cleavage complex - a potentially new drug targetIris Alchanati, Carmit Teicher, Galit Cohen, et al.
British Journal of Haematology|November 28, 2018
Venetoclax for chronic lymphocytic leukaemia patients who progress after more than one B-cell receptor pathway inhibitorWilliam G Wierda, John C Byrd, Matthew S Davids, et al.
The Medical Journal of Australia|August 27, 2009
Health and mortality consequences of abdominal obesity: evidence from the AusDiab studyAdrian J Cameron, David W Dunstan, Neville Owen, et al.
Blood|March 23, 2017
Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapyAjay K Gopal, Brad S Kahl, Christopher R Flowers, et al.
Genome Research|August 26, 2016
A generic, cost-effective, and scalable cell lineage analysis platformTamir Biezuner, Adam Spiro, Ofir Raz, et al.
Journal of Population Therapeutics and Clinical Pharmacology = Journal De La Therapeutique Des Populations Et De La Pharmacologie Clinique|August 7, 2020
Treatment algorithm for the use of psychopharmacological agents in individuals prenatally exposed to alcohol and/or with diagnosis of fetal alcohol spectrum disorder (FASD)Mansfield Mela, Ana Hanlon-Dearman, A G Ahmed, et al.
American Journal of Hematology|January 2, 2025
Treatment of Relapsed/Refractory CLL Patients With PI3Kδ Inhibitor and Anti-CD20 Antibody Rapidly Decreases Tumor Burden but Could Induce ResistanceJennifer E Bruno, Christine A Herne, Andrea M Baran, et al.
Pageof 104